SG/PUT/PFIZER INC/25/0.1/20.12.24 Stock

DE000SU27307

Market Closed - Bid/Ask 02:18:56 2024-07-16 pm EDT			After market 02:52:06 pm
0.046 ^EUR	-6.12%		0.05	+8.70%

Current month	-40.51%
1 month	-47.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart PFIZER, INC.

Latest news about PFIZER, INC.

Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis	Jul. 15	CI
Health Care Up as Momentum Builds -- Health Care Roundup	Jul. 12	DJ
UBS Raises Price Target on Pfizer to $30 From $28, Maintains Neutral Rating	Jul. 12	MT
CureVac Provides Update on Trial Dates for Patent Litigation across Multiple Geographies against Pfizer, BioNTech	Jul. 12	AQ

More news

Quotes 5-day view

Date	Price	Change
24-07-16	0.046	-6.12%
24-07-15	0.049	-10.91%
24-07-12	0.055	-14.06%
24-07-11	0.064	-11.11%
24-07-10	0.072	-13.25%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 02:18 pm EDT

More quotes

Static data

Product type	Warrant Plain-Vanilla
Buy / Sell	PUT
Underlying	PFIZER, INC.
Issuer	Société Générale
WKN	SU2730
ISIN	DE000SU27307
Date issued	2023-12-05
Strike	25 $
Maturity	2024-12-20 (157 Days)
Parity	10 : 1
Emission price	0.16 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.24 €
Lowest since issue	0.046 €
Spread	0.01 €
Spread %	17.86%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sector

More about the company